In this study, we also selected calreticulin (CRT, a multifunctional protein predominantly located in endoplasmic reticulum) as an immune adjuvant to amplify the specific anti-myeloma immune response elicited by the CS1-DNA vaccine. Here, CALR is linked to plasma cell myeloma.